European Venture Firm LSP Floats Public-Biotech Focused Fund
This article was originally published in The Pink Sheet Daily
Executive Summary
A new vehicle dedicated to public-side investing follows in the footsteps of other traditional life-science VCs; the focus is on small- and mid-cap listed European groups.